CBDYOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Target Group Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $431.92K
- P/E (TTM)
- –
- Dividend yield
- –
Target statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Target | Industry median |
|---|---|---|
| Market Cap | $431.92K | $197.05M |
| Enterprise Value | $7.76M | $106.56M |
| PS Ratio | 0.12 | 3.93 |
Enterprise value
| Measure | Target | Industry median |
|---|---|---|
| EV / Sales | 2.22 | 2.69 |
| EV / EBITDA | 39.47 | 14.86 |
Income (trailing twelve months)
| Measure | Target | Industry median |
|---|---|---|
| Revenue | $3.50M | $57.94M |
| Gross Profit | $1.37M | $90.47M |
| Pretax Income | -$1.82M | -$14.45M |
| Net Income | -$1.82M | -$22.46M |
| EBITDA | $196.63K | -$16.91M |
| EPS (Diluted) | -$0.00 | -$0.83 |
Margins
| Measure | Target | Industry median |
|---|---|---|
| Gross Margin | 39.2% | 52.3% |
| Pretax Margin | -52.1% | -13.0% |
| Profit Margin | -52.1% | -39.2% |
| EBITDA Margin | 5.63% | -31.3% |
Returns
| Measure | Target | Industry median |
|---|---|---|
| Return on Assets (ROA) | -29.7% | -41.0% |
Growth
| Measure | Target | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -30.7% | 6.01% |
| Revenue Growth (5Y CAGR) | 164.5% | 6.42% |
Balance sheet
| Measure | Target | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $5.91K | $62.42M |
| Total Debt | $7.33M | $120.13M |
| Net Cash (Debt) | -$7.33M | $15.68M |
| Net Cash Per Share | -$0.01 | $0.65 |
| Equity (Book Value) | -$8.66M | $48.79M |
| Book Value Per Share | -$0.01 | $1.36 |
| Tangible Book Value | -$8.91M | $23.06M |
| Working Capital | -$11.23M | $75.77M |
Financial position
| Measure | Target | Industry median |
|---|---|---|
| Current Ratio | 0.17 | 3.30 |
| Quick Ratio | 0.04 | 2.39 |
| Debt / EBITDA | 37.30 | 3.35 |
| Net Debt / EBITDA | 37.27 | 2.22 |
Cash flow (trailing twelve months)
| Measure | Target | Industry median |
|---|---|---|
| Operating Cash Flow | -$1.07M | -$12.35M |
Efficiency
| Measure | Target | Industry median |
|---|---|---|
| Asset Turnover | 0.57 | 0.38 |
| Inventory Turnover | 1.25 | 2.67 |
| Revenue Per Employee | $87.38K | $398.96K |
| Profits Per Employee | -$45.55K | -$732.08K |
| Employee Count | 40 | 73 |
Dividends and yields
| Measure | Target | Industry median |
|---|---|---|
| Earnings Yield | -421.8% | -21.2% |
Shares
| Measure | Target | Industry median |
|---|---|---|
| Shares Outstanding | 617,026,000 | 59,128,900 |
| Shares Change (YoY) | -15.2% | 11.1% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 617,026,000 | 48,744,500 |
| Shares Held by Insiders | 0.00% | 11.8% |
Scores
| Measure | Target | Industry median |
|---|---|---|
| Altman Z-Score | -9.90 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Target's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.